Eli Lilly Corp. sell Traumtanz
Start price
03.10.24
/
50%
€804.00
Target price
03.10.25
€880.00
Performance (%)
0.19%
End price
11:15
€805.50
Summary
This prediction ended on 11:15 with a price of €805.50. The SELL prediction by Traumtanz for Eli Lilly Corp. closed nearly unchanged from the start price. Traumtanz has a follow-up prediction for Eli Lilly Corp., but this time predicts that Eli Lilly Corp. is a Buy. Traumtanz has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Eli Lilly Corp. | 0.19% |
iShares Core DAX® | -1.471% |
iShares Nasdaq 100 | -0.486% |
iShares Nikkei 225® | -2.115% |
iShares S&P 500 | 0.394% |
According to Traumtanz what are the pros and cons of Eli Lilly Corp. for the foreseeable future?
Pros
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Valuable balance sheet
ROE higher than 10% per year
Normal challenges to pay loans and raise capital
Good culture
Innovative
Some uniques
Growths faster than the competition
Sustainability is important
Stable Large shareholder and/or long term investor
Small cyclical dependencies
Future proof or reliable business model
Capable Management
Well known brand
Cons
Comments by Traumtanz for this prediction
In the thread Eli Lilly Corp. diskutieren
Sell mit Kursziel 880,0
In the thread Trading Eli Lilly Corp.
Sell beendet
Current prediction by Traumtanz for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€805.50
11:15
11:15
€880.00
04.10.25
04.10.25
-0.35%
18:20
18:20
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Stopped prediction by Traumtanz for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€871.10
03.09.24
03.09.24
€880.00
03.09.25
03.09.25
-7.70%
03.10.24
03.10.24
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€529.00
18.12.23
18.12.23
€558.00
18.12.24
18.12.24
6.62%
06.01.24
06.01.24
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€526.00
14.12.23
14.12.23
€558.00
14.12.24
14.12.24
0.57%
18.12.23
18.12.23
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€568.50
11.10.23
11.10.23
€558.00
11.10.24
11.10.24
-7.48%
14.12.23
14.12.23
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€533.50
19.09.23
19.09.23
€558.00
19.09.24
19.09.24
6.56%
11.10.23
11.10.23
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€555.50
15.09.23
15.09.23
€558.00
15.09.24
15.09.24
-3.96%
19.09.23
19.09.23
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€502.50
17.08.23
17.08.23
€510.00
17.08.24
17.08.24
10.75%
13.09.23
13.09.23
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€388.00
05.05.23
05.05.23
€395.00
05.05.24
05.05.24
3.52%
12.05.23
12.05.23
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€362.80
29.10.22
29.10.22
€400.00
29.10.23
29.10.23
6.95%
05.05.23
05.05.23
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€338.70
07.10.22
07.10.22
€350.00
07.10.23
07.10.23
7.12%
29.10.22
29.10.22
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€125.04
16.10.20
16.10.20
€120.00
04.11.21
04.11.21
4.56%
09.12.20
09.12.20
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€126.00
14.10.20
14.10.20
€120.00
16.10.20
16.10.20
-0.76%
16.10.20
16.10.20
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€134.00
07.04.20
07.04.20
€175.00
10.06.20
10.06.20
-0.91%
10.06.20
10.06.20
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€106.50
24.01.19
24.01.19
€126.28
28.01.19
28.01.19
-3.53%
28.01.19
28.01.19
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€99.33
19.12.18
19.12.18
€126.28
07.01.19
07.01.19
2.04%
07.01.19
07.01.19
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market